The beneficial impact of FGF19 on lipid, glucose and BA homeostasis raise the possibility to pursue FGF19 as a therapeutic target for diabetes, metabolic syndrome and cholestatic liver diseases. Here, FGF19 is linked to Cholestatic liver disease.